Tiziana Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ivor R. Elrifi, with a market cap of $156.5M.
Common questions about Tiziana Life Sciences
Tiziana Life Sciences is scheduled to report earnings for Q4 2025 on June 18, 2026 before market open.
Tiziana Life Sciences has approximately 9 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.